What is a stock summary page? Click here for an overview.
Business Description
Nevro Corp
NAICS : 334510
SIC : 3845
ISIN : US64157F1030
Description
Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. The company generates the majority of its revenue in the United States.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.17 | |||||
| Equity-to-Asset | 0.42 | |||||
| Debt-to-Equity | 1.09 | |||||
| Debt-to-EBITDA | -3.52 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -0.6 | |||||
| Beneish M-Score | -3.57 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -0.3 | |||||
| 3-Year EBITDA Growth Rate | 13.2 | |||||
| 3-Year EPS without NRI Growth Rate | 3.8 | |||||
| 3-Year FCF Growth Rate | 20.3 | |||||
| 3-Year Book Growth Rate | -11 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 13.13 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 3.1 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 72.63 | |||||
| 9-Day RSI | 71.49 | |||||
| 14-Day RSI | 70.36 | |||||
| 3-1 Month Momentum % | 54.03 | |||||
| 6-1 Month Momentum % | 8.32 | |||||
| 12-1 Month Momentum % | -60.26 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.62 | |||||
| Quick Ratio | 3.62 | |||||
| Cash Ratio | 2.84 | |||||
| Days Inventory | 309.48 | |||||
| Days Sales Outstanding | 66.66 | |||||
| Days Payable | 58.53 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -2.6 | |||||
| Shareholder Yield % | -19.04 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 65.98 | |||||
| Operating Margin % | -23.18 | |||||
| Net Margin % | -27.77 | |||||
| FCF Margin % | -7.15 | |||||
| ROE % | -42 | |||||
| ROA % | -19 | |||||
| ROIC % | -38.91 | |||||
| 3-Year ROIIC % | -6.8 | |||||
| ROC (Joel Greenblatt) % | -48.11 | |||||
| ROCE % | -16.86 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.53 | |||||
| PB Ratio | 0.96 | |||||
| Price-to-Tangible-Book | 1.07 | |||||
| EV-to-EBIT | -2.14 | |||||
| EV-to-Forward-EBIT | -17.61 | |||||
| EV-to-EBITDA | -2.56 | |||||
| EV-to-Forward-EBITDA | -19.6 | |||||
| EV-to-Revenue | 0.45 | |||||
| EV-to-Forward-Revenue | 0.44 | |||||
| EV-to-FCF | -6.27 | |||||
| Price-to-GF-Value | 0.29 | |||||
| Price-to-Median-PS-Value | 0.08 | |||||
| Price-to-Net-Current-Asset-Value | 1.44 | |||||
| Earnings Yield (Greenblatt) % | -46.73 | |||||
| FCF Yield % | -13.03 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:NVRO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nevro Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 408.518 | ||
| EPS (TTM) ($) | -3.05 | ||
| Beta | 0.62 | ||
| 3-Year Sharpe Ratio | -1.2 | ||
| 3-Year Sortino Ratio | -1.39 | ||
| Volatility % | 70.35 | ||
| 14-Day RSI | 70.36 | ||
| 14-Day ATR ($) | 0.051949 | ||
| 20-Day SMA ($) | 5.784 | ||
| 12-1 Month Momentum % | -60.26 | ||
| 52-Week Range ($) | 3.165 - 14.7 | ||
| Shares Outstanding (Mil) | 38.37 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nevro Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nevro Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Nevro Corp Frequently Asked Questions
What is Nevro Corp(NVRO)'s stock price today?
The current price of NVRO is $5.85. The 52 week high of NVRO is $14.70 and 52 week low is $3.17.
When is next earnings date of Nevro Corp(NVRO)?
The next earnings date of Nevro Corp(NVRO) is 2025-05-07 Est..
Does Nevro Corp(NVRO) pay dividends? If so, how much?
Nevro Corp(NVRO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers